⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27279824 | 0.98 | — | — | |
| SCHEMBL6616930 | 0.70 | — | — | |
| SCHEMBL27905776 | 0.64 | — | — | |
| SCHEMBL28742567 | 0.62 | — | — | |
| SCHEMBL20577619 | 0.62 | — | — | |
| SCHEMBL16094456 | 0.62 | — | — | |
| SCHEMBL4731811 | 0.62 | — | — | |
| SCHEMBL3301085 | 0.60 | — | — | |
| SCHEMBL13286891 | 0.59 | — | — | |
| SCHEMBL18908546 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023049364-A1 | PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS | XENON PHARMACEUTICALS INC. (CA) | 2023-03-30 | — | — | WO | claimed |
| EP-3212634-A1 | COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE | OREGON STATE UNIVERSITY (US) | 2017-09-06 | — | — | EP | claimed |
| CN-106349244-A | Benzo imidazo quinazoline dimethyl oxygen benzene oxygen acetyl-AA-OBzl, as well as synthesis, activity and application thereof | 首都医科大学 | 2017-01-25 | — | — | CN | claimed |
| CN-106328948-A | Preparation method of novel lithium battery negative pole material based on [Zn(BIBBA)2]n | 华南师范大学 | 2017-01-11 | — | — | CN | claimed |
| WO-2016069780-A1 | COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE | OREGON STATE UNIVERSITY (US) | 2016-05-06 | — | — | WO | claimed |
| EP-2318376-A1 | BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2011-05-11 | — | — | EP | claimed |
| WO-2010110686-A1 | PYRIMIDINYL AND 1,3,5 TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY | PATHWAY THERAPEUTICS LIMITED (NZ) | 2010-09-30 | — | — | WO | claimed |
| WO-2010017401-A1 | BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-02-11 | — | — | WO | claimed |
| WO-2008140239-A1 | IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-11-20 | — | — | WO | claimed |
| WO-2008100564-A1 | LTA4H MODULATORS AND USES THEROF | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-08-21 | — | — | WO | claimed |
| CN-1823242-A | Anisotropic fluorescent thin crystal film and backlight system and liquid crystal display incorporating the same | OPTIVA INC (JP) | 2006-08-23 | — | — | CN | claimed |
| EP-1660491-A1 | BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-05-31 | — | — | EP | claimed |
| WO-2005012296-A1 | BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-10 | — | — | WO | claimed |
| CN-1222070-A | Aqueous nail coating compsn. containing copolymerized colorants | EASTMAN CHEM CO (US) | 1999-07-07 | — | — | CN | claimed |
| CN-116410184-B | Quinazolinone ketene azole compound, and preparation method and application thereof | 西南大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20240158439-A1 | INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY | PROVID PHARMACEUTICALS INC. | 2024-05-16 | — | — | US | disclosed |
| CN-110950749-B | IDO inhibitor and preparation method and application thereof | 中国科学院广州生物医药与健康研究院 | 2023-07-25 | — | — | CN | disclosed |
| WO-1997038992-A1 | PIPERIDINYLPYRAMIDINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1997-10-23 | — | — | WO | disclosed |
| US-4251623-A | Imaging process involving thermal decomposition of Te(II) coordination complexes | EASTMAN KODAK COMPANY (US) | 1981-02-17 | — | — | US | disclosed |
| US-4188218-A | Images formed by decomposition of Te (II) coordination complexes | EASTMAN KODAK COMPANY (US) | 1980-02-12 | — | — | US | disclosed |